Literature DB >> 10228134

Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease.

V I Peinado1, J A Barberá, P Abate, J Ramírez, J Roca, S Santos, R Rodriguez-Roisin.   

Abstract

Endothelial dysfunction and intimal thickening have been shown in pulmonary arteries (PA) of patients with mild chronic obstructive pulmonary disease (COPD). To investigate whether an inflammatory process related to tobacco smoking might be involved in the development of pulmonary vascular abnormalities in COPD, we characterized the inflammatory cell infiltrate and the endothelium-dependent relaxation in PA of 39 patients who underwent lung resection, divided into three groups: "nonsmokers" (n = 7); "smokers," with normal lung function (n = 12); and "COPD" (n = 20). Endothelium-dependent relaxation was assessed in vitro by exposing PA rings to adenosine diphosphate (ADP). Inflammatory cell types were identified by immunohistochemistry. PA of COPD patients developed lower relaxation in response to ADP than nonsmokers and smokers. The number of inflammatory cells was increased in PA of COPD compared with the other two groups. This cell infiltrate was largely constituted by T lymphocytes. The CD8(+) T-cell subset was increased in both smokers and COPD compared with nonsmokers, yielding a reduction of the CD4(+)/CD8(+) ratio. The intensity of the inflammatory infiltrate correlated with both the endothelium-dependent relaxation and the intimal thickness. We conclude that cigarette smoking induces a CD8(+) T-lymphocyte infiltrate in PA, which is associated with the impairment of the vessel's structure and function, suggesting the potential involvement of an inflammatory process in the pathogenesis of pulmonary vascular abnormalities in the early stage of COPD.

Entities:  

Mesh:

Year:  1999        PMID: 10228134     DOI: 10.1164/ajrccm.159.5.9807059

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  57 in total

1.  Pulmonary hypertension in a stable community-based COPD population.

Authors:  Vadim Fayngersh; Fotios Drakopanagiotakis; F Dennis McCool; James R Klinger
Journal:  Lung       Date:  2011-08-04       Impact factor: 2.584

2.  Saikosaponin a Inhibits Cigarette Smoke-Induced Oxidant Stress and Inflammatory Responses by Activation of Nrf2.

Authors:  Ru-Jie Chen; Xian-Yang Guo; Bi-Huan Cheng; Yu-Qiang Gong; Bin-Yu Ying; Meng-Xiang Lin
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

3.  Expression of protease activated receptor-2 (PAR-2) in central airways of smokers and non-smokers.

Authors:  D Miotto; M D Hollenberg; N W Bunnett; A Papi; F Braccioni; P Boschetto; F Rea; A Zuin; P Geppetti; M Saetta; P Maestrelli; L M Fabbri; C E Mapp
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

4.  Quantitative computed tomographic measurement of a cross-sectional area of a small pulmonary vessel in nonsmokers without airflow limitation.

Authors:  Iwao Uejima; Shin Matsuoka; Tsuneo Yamashiro; Kunihiro Yagihashi; Yasuyuki Kurihara; Yasuo Nakajima
Journal:  Jpn J Radiol       Date:  2011-05-24       Impact factor: 2.374

5.  MicroRNA Dysregulation in Pulmonary Arteries from Chronic Obstructive Pulmonary Disease. Relationships with Vascular Remodeling.

Authors:  Melina M Musri; Núria Coll-Bonfill; Bradley A Maron; Víctor I Peinado; Rui-Sheng Wang; Jordi Altirriba; Isabel Blanco; William M Oldham; Olga Tura-Ceide; Jessica García-Lucio; Benjamin de la Cruz-Thea; Gunter Meister; Joseph Loscalzo; Joan A Barberà
Journal:  Am J Respir Cell Mol Biol       Date:  2018-10       Impact factor: 6.914

Review 6.  Cardiac disease in chronic obstructive pulmonary disease.

Authors:  Jeremy A Falk; Steven Kadiev; Gerard J Criner; Steven M Scharf; Omar A Minai; Philip Diaz
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 7.  Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management.

Authors:  Joan Albert Barberà; Isabel Blanco
Journal:  Drugs       Date:  2009-06-18       Impact factor: 9.546

Review 8.  Differences in airway remodeling between asthma and chronic obstructive pulmonary disease.

Authors:  Kazutetsu Aoshiba; Atsushi Nagai
Journal:  Clin Rev Allergy Immunol       Date:  2004-08       Impact factor: 8.667

9.  Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema.

Authors:  Shin Matsuoka; George R Washko; Tsuneo Yamashiro; Raul San Jose Estepar; Alejandro Diaz; Edwin K Silverman; Eric Hoffman; Henry E Fessler; Gerard J Criner; Nathaniel Marchetti; Steven M Scharf; Fernando J Martinez; John J Reilly; Hiroto Hatabu
Journal:  Am J Respir Crit Care Med       Date:  2009-10-29       Impact factor: 21.405

Review 10.  Hyperinflation and its management in COPD.

Authors:  Luis Puente-Maestu; William W Stringer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.